Skip to the content
halfrx
← All providers and medications

Compounded tirzepatide vs Ozempic (semaglutide, diabetes label)

Verdict

Ozempic is the better choice of the two, winning on regulatory and complaint risk and approved product or compounded copy (halfrx score 5.1 against 1.8).

Computed from the stored fields, so it moves when a price does. Nothing here is written by hand or by a model.

Which is cheaper, Compounded tirzepatide or Ozempic (semaglutide, diabetes label)?

Compounded tirzepatide is $199–$359 a month all-in, the range its sellers here charge, oldest read 2026-09-13; Ozempic (semaglutide, diabetes label) is $199–$499, read from its own page on 2026-09-22. Every axis below is computed from stored fields rather than written by hand, so the comparison moves when a price does. They were last checked on 2026-09-13 and 2026-09-22. Flags recorded here: Compounded tirzepatide — not FDA approved, manufacturer lawsuit, supply risk. Ozempic (semaglutide, diabetes label) is an FDA-approved product and Compounded tirzepatide is a compounded copy made under the pharmacy-compounding exemption, which is a legal status rather than a quality claim. The published formula scores them 1.8 and 5.1 out of 10, arithmetic over the same stored fields rather than an editor's preference. Cost here is scored on what a patient pays once titrated, never on the entry price, because an introductory rate covers the months before anybody has reached the dose they stay on.

Head to head

Compounded tirzepatide against Ozempic (semaglutide, diabetes label), one row per axis, with the side that wins each axis marked.
What decides itCompounded tirzepatide
$199–$359/mo
Ozempic
$199–$499/mo
Entry priceBoth start at $199/mo.tiedtied
Regulatory and complaint riskCompounded tirzepatide: 3 serious flags. Ozempic (semaglutide, diabetes label): none.—✓ better here
Approved product or compounded copyOzempic (semaglutide, diabetes label) supplies an FDA-approved product; Compounded tirzepatide supplies a compounded preparation, which the FDA does not review for safety, efficacy or quality and which can stop shipping if its pharmacy is enjoined.—✓ better here
Compounded tirzepatide publishes no page halfrx will send you toGo to Ozempic ↗

What separates these two, price aside

  • These are different molecules — tirzepatide against semaglutide — so this is a comparison of two treatments, not of two prices for one.
503A/503B compounding pharmacies
Compounded tirzepatide
1.8
$199–$359/mo all-in
checked 2026-09-13 — no maintenance-dose price
Not FDA approvedCompounding legal riskManufacturer lawsuitSupply risk
$199–$499/mo all-in
verified 2026-09-22
Off-label for weightBoxed warning

Compounded tirzepatide

Pros

  • +Access to tirzepatide, the most effective molecule, at $199–$359/mo against Zepbound's $1,086 list.[1]
  • +Vial dosing allows finer titration than branded pens.[1]

Cons

  • −Not FDA approved — no review of safety, efficacy or manufacturing quality.[1]
  • −Eli Lilly has active lawsuits against compounded tirzepatide sellers, including Henry Meds. A ruling against your provider ends your supply.[2]
  • −The tirzepatide shortage that legally permitted mass compounding has been resolved, so the category now operates on contested legal ground.[2]
  • −Zepbound vials through LillyDirect start at $299/mo — the branded gap is far smaller than it was, which weakens the only argument for compounding.[1]

Ozempic (semaglutide, diabetes label)

Pros

  • +New self-pay patients pay $199 for the first two monthly fills on TrumpRx, through 31 December 2026, then $349 a month at 0.25 to 1 mg.[2]
  • +Identical active molecule to Wegovy.[2]
  • +If you have type 2 diabetes, this is the on-label product and the one insurance is most likely to cover.[2]

Cons

  • −Using it for weight loss without diabetes is off-label. Insurers deny it on that basis and prescribers vary in willingness.[2]
  • −Its top dose is 2 mg, against 2.4 mg for standard Wegovy and 7.2 mg for Wegovy HD; the Ozempic label reports no weight-loss percentage to set beside Wegovy's.[5]
  • −Prescribing it off-label for weight competes with diabetes patients for supply — a recurring shortage driver.[2]

Comparisons are computed from the fields on each card, not written by hand or by a model, so they change when the data does. Information only, not medical advice. halfrx may earn a commission from some links, which never changes what a comparison says.

Everything on Compounded tirzepatide

Everything on Ozempic

The registers and documents behind both sides

Two cards compared on the same checks. These are the registers those checks were run against, and the FDA's own pages where either side is a compounded product.

Compounded tirzepatide against Ozempic, answered

Is Compounded tirzepatide or Ozempic better for weight loss?
Only Ozempic has a trial figure recorded here: 6.4% average weight loss, worked out from the kilograms on its label. Compounded tirzepatide has none on this site — a compounded preparation has no trial of its own, so the two cannot be compared on effect and this page does not pick one on it.
Which is cheaper, Compounded tirzepatide or Ozempic?
Both start at $199 a month. For Compounded tirzepatide ($199–$359) only a starting price is published, not one for the maintenance dose, so which costs less once titrated cannot be worked out here.
Can you switch between Compounded tirzepatide and Ozempic?
They are different molecules, so this is a change of medication rather than of brand, and the one you move to is started on its own dosing schedule.
Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.